Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

Spectrum Presentaion Tweaked.

I believe it's the same as the Oppenheimer 29th Annual Healthcare Conference Presentation. The difference from the Jan Presentation is they added a slide "Executing a New Direction for Spectrum" about their Divestiture of Legacy Assets Completed for a $160MM Upfront Cash Payment; and they tweaked the slide on "Poziotinib–2018 and 2019 Milestones" where Z20 cohort topline went from "2nd half" to "4th Q" as we found out at Oppenheimer. Bummed by cohort 1 results pushed to 4Q but being a glass half full kind of guy hopefully it's because the DoR is taking longer to mature. Still don't see why they don't report interim results at ASCO or SABCS. We shall see. Come on Spectrum.

http://investor.sppirx.com/index.php/static-files/202ee8f6-aecf-4ab5-9bbf-91af8de17c28